ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Updates

Clear All

SUB-TYPE: CLASS 3 RECALL

Class 3 Recall on Beconase Aqueous Nasal Spray GSK

Update: Returns for credit must be received by Friday 20th March 2020

Glaxo Wellcome UK Ltd T/A GSK has informed us of an issue related to error in the decommissioning of the below batch. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED.' Although there is no risk to product quality, any remaining stock should be quarantined and returned.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
383307BECONASE AQ NASAL 50MCGGLAXOSMITHKLINE UK LTDK84X

For stock control enquiries please contact 0800 221441.

For medical information enquiries please contact ukmedinfo@gsk.com , via the Live Chat facility or on 0800 221 441 (option 2).

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

Class 3 Recall on Beconase Aqueous Nasal Spray GSK

Update: Returns for credit must be received by Friday 20th March 2020

Glaxo Wellcome UK Ltd T/A GSK has informed us of an issue related to error in the decommissioning of the below batch. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED.' Although there is no risk to product quality, any remaining stock should be quarantined and returned.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
383307BECONASE AQ NASAL 50MCGGLAXOSMITHKLINE UK LTDK84X

For stock control enquiries please contact 0800 221441.

For medical information enquiries please contact ukmedinfo@gsk.com , via the Live Chat facility or on 0800 221 441 (option 2).

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Emerade Auto-Injector 150 Bausch & Lomb UK

Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 150 microgram auto-injectors (also referred to as pens) from patients due to an error in one component of the auto-injector believed to cause some pens to fail to activate and deliver adrenaline.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3849221EMERADE 150 AUTO-INJECTORBAUSCH & LOMB UKALL STOCK

For stock enquiries please contact Bausch & Lomb Customer Services, Tel: 020 8781 2991
 

For medical information enquiries please contact the Pharmacovigilance and Medical Information Officer, Tel: 0208 781 5523, Email: Pharmacovigilance.UK@bausch.com

Email: Pharma_CS@bausch.com - please note, only in-date pens that are returned by patients, will be refunded, (i.e. expiry date of March 2020 onwards).

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Tetrabenazine Tab 25mg AOP Orphan Pharmaceuticals AG

AOP Orphan Pharmaceuticals AG is recalling all unexpired stock of the below batch of Tetrabenazine 25 mg tablets (from pharmacies and wholesalers) as a precautionary measure due to out of specification results for the assay, obtained during routine stability testing.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch
6838841TETRABENAZINE TAB 25MGAOP Orphan Pharmaceuticals AGT1704UK
3580073TETRABENAZINE TAB 25MGAOP Orphan Pharmaceuticals AGT1704UK

For more information or medical information queries, please contact medinfo@aoporphan.com.

For stock control queries, please contact orderservice@aoporphan.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Alliance Healtchare do not stock this batch therefore we are not accepting stock returns.
 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in Use on Oxylan Prolonged-Release Tablets

G.L Pharma GmbH T/A Healthcare Pharma Ltd has informed us that the Patient Information Leaflet (PIL) within the packs for the specified batches is missing important safety relevant text changes.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch
6359814OXYCODONE PR TAB 10MGHealthcare Pharma Ltd9F115A
9F116A
6359822OXYCODONE PR TAB 20MGHealthcare Pharma Ltd9J114A
6359830OXYCODONE PR TAB 40MGHealthcare Pharma Ltd9F119A
6359798OXYCODONE PR TAB 80MGHealthcare Pharma Ltd9F120A
8113458OXYCODONE SR TAB 10MGHealthcare Pharma Ltd9F115A
9F116A
8456030OXYCODONE SR TAB 20MGHealthcare Pharma Ltd9J114A
8456014OXYCODONE SR TAB 40MGHealthcare Pharma Ltd9F119A
8455917OXYCODONE SR TAB 80MGHealthcare Pharma Ltd9F120A
3726122OXYCODONE PR TAB 10MGHealthcare Pharma Ltd9F115A
9F116A
3726130OXYCODONE PR TAB 20MGHealthcare Pharma Ltd9J114A
3726148OXYCODONE PR TAB 40MGHealthcare Pharma Ltd9F119A
3726155OXYCODONE PR TAB 80MGHealthcare Pharma Ltd9F120A
1196971OXYCODONE PR TAB 80MG/td>Healthcare Pharma Ltd9F120A

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will be required to follow the instructions as per the drug alert.

For more information or medical information queries, please contact: GL Pharma GmbH on +43 3136 82577 or office@gl-pharma.at.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Recall on Glutafin Gf Pizza Bases

DR SCHAR is recalling the below batch because the Incorrect product is in the correct outer case.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3341112GLUTAFIN GF PIZZA BASESDR SCHAR220620C

For all enquiries, please contact DR SCHAR Customer services on 0800 161 5838
 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in Use on Memantine 10mg Film-Coated Tablets

Crescent Pharma Ltd has informed us of a discrepancy on the product packaging for the below batches. The discrepancy relates to the incorrect quantity printed on one side (end flap) of the packs in error. The incorrect end flap states that the quantity of tablets within the pack is 30, however this is incorrect and should state 28 as per all other sides of the pack, (see Annex 1). The other product details on the pack including the name, strength and pharmaceutical form of the medicine are correct.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
8130825MEMANTINE HYD TAB 10MGCRESCENT PHARMA LTD10819
20819
11119
1208925MEMANTINE TABS 10MGCRESCENT PHARMA LTD10819
20819
11119
1182922MEMANTINE HCL TAB 10MGCRESCENT PHARMA LTD10819
20819
11119
1148048MEMANTINE TAB 10MGCRESCENT PHARMA LTD10819
20819
11119

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will be required to follow the instructions as per the drug alert.

For more information or medical information queries, please contact: Crescent Pharma Ltd. Medical Information Department on +00351 214643225, via email on tiago.barca@pharsolution.com or +44 (0) 1256 772740.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This is a caution in use only we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Gliclazide Tab 40mg

Accord-UK Limited is recalling all unexpired stock of Gliclazide 40 mg Tablets (Northstar Livery) from pharmacies and wholesalers as a precautionary measure due to out of specification results for dissolution, obtained during routine stability testing..

Please visit the: MHRA Website .

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
1217223GLICLAZIDE TAB 40MG ALMACCORD-UK LTD (NORTHSTAR LIVERY)GU50
1217231GLICLAZIDE TAB 40MG TEVACCORD-UK LTD (NORTHSTAR LIVERY)GU50
1207596GLICLAZIDE TAB 40MG ACTACCORD-UK LTD (NORTHSTAR LIVERY)GU50
8427023OTCD GLICLAZIDE TAB 40MGACCORD-UK LTD (NORTHSTAR LIVERY)GU50
8107104GLICLAZIDE TAB 40MGACCORD-UK LTD (NORTHSTAR LIVERY)GU50

ALLIANCE DO NOT STOCK. Please return all affected stock to your original supplier for credit.

For stock control enquiries please contact Accord Customer Services Team on 0800 373573.

For medical information enquiries please contact Accord Medical Information Department on 01271 385257.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Recall on Iohexol Glenmark Pharmaceuticals

As a precautionary measure, Glenmark Pharmaceuticals is recalling the above lots to wholesaler and pharmacy level due to an out of specification result from the ongoing stability studies. The out of specification result for all batches of Iohexol distributed in United Kingdom are up to 4% over the upper specifications limits for content. (105%).

Please visit the: MHRA Website .

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
1223726IOHEXOL 300MG/50MLGLENMARK PHARMACEUTICALS1806007
1223759IOHEXOL 300MG/75MLGLENMARK PHARMACEUTICALS1805752
1223700IOHEXOL 300MG/100MLGLENMARK PHARMACEUTICALS1805640
1223692IOHEXOL 350MG/50MLGLENMARK PHARMACEUTICALS1806771
1223734IOHEXOL 350MG/100MLGLENMARK PHARMACEUTICALS1805641

For medical information enquiries, please contact: Glenmark medical information: Tel: 0800 458 0383 e-mail: medical_information@glenmarkpharma.com

For stock enquiries, please contact: Matthew Jeffery Tel: 01923 202950 | (Extn) 3010 e-mail: Matthew.Jeffery@glenmarkpharma.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Ranitidine Tablets 150mg & 300mg

Medreich Plc is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Please visit the: MHRA Website .

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
7056195RANITIDINE TAB 150MGMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
1069087RANITIDINE TAB 150MG ACTMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
7056203RANITIDINE TAB 300MGMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
1069046RANITIDINE TAB 300MG ACTMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
1179191RANITIDINE TAB 300MG ACTMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE

For stock control enquiries please contact Medreich Plc Customer Service team on 020 8831 1580 or cs_team@medreich.co.uk

For medical information enquiries please contact Medreich Plc Pharmacovigilance Department on 020 8831 1580 or info@medreich.co.uk .

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.